Gary Ingenito - Mar 5, 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Stock symbol
CPRX
Transactions as of
Mar 5, 2025
Transactions value $
-$4,390,610
Form type
4
Date filed
3/7/2025, 05:00 PM
Previous filing
Feb 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $101K +44.9K +65.2% $2.24 114K Mar 5, 2025 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$992K -44.9K -39.47% $22.09 68.9K Mar 5, 2025 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Options Exercise $403K +180K +261.49% $2.24 249K Mar 6, 2025 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$3.9M -180K -72.34% $21.67 68.9K Mar 6, 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -44.9K -4.42% $0.00 970K Mar 5, 2025 Common Stock 44.9K $2.24 Direct F4
transaction CPRX Options to purchase common stock Options Exercise $0 -180K -18.56% $0.00 790K Mar 6, 2025 Common Stock 180K $2.24 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in a range between $22.00 and $22.285 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in a range between $21.60 and $21.95 per share.
F4 Options vested in three annual tranches beginning on December 19, 2019.